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Summary
The mechanism responsible for trafficking of monocyte-derived
macrophages into kidney in the puromycin aminonucleoside model of
nephrotic syndrome in rats (PAN-NS), and the significance of this infiltra-
tion, remain largely unknown. CXCL10, a chemokine secreted in many T
helper type 1 (Th1) inflammatory diseases, exhibits important roles in traf-
ficking of monocytes and activated T cells. We hypothesized that induction
of circulating interferon (IFN)-γ and glomerular tumour necrosis factor
(TNF)-α during PAN-NS would stimulate the release of CXCL10 by
podocytes, leading to infiltration of activated immune cells and greater
glomerular injury. We found that serum IFN-γ, glomerular Cxcl10 mRNA
and intra- and peri-glomerular macrophage infiltration were induced
strongly during the late acute phase of PAN-NS in Wistar rats, but not in
nude (Foxn1rnu/rnu) rats lacking functional effector T lymphocytes.Wistar rats
also developed significantly greater proteinuria than nude rats, which could
be abolished by macrophage depletion. Stimulation of cultured podocytes
with both IFN-γ and TNF-α markedly induced the expression of Cxcl10
mRNA and CXCL10 secretion. Together, these data support our hypothesis
that increased circulating IFN-γ and glomerular TNF-α induce synergisti-
cally the production and secretion of CXCL10 by podocytes, attracting acti-
vated macrophages into kidney tissue. The study also suggests that IFN-γ,
secreted from Th1 lymphocytes, may prime proinflammatory macrophages
that consequently aggravate renal injury.
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Introduction
Nephrotic syndrome (NS) is a condition with diverse aeti-
ologies and common symptoms that are largely a result of
massive loss of serum proteins in the urine. The most
common subtype of NS is minimal change nephrotic syn-
drome (MCNS), in which the glomerular injury leading to
protein leakage is a consequence of effacement of the ter-
tiary ‘foot’ processes of visceral epithelial cells (podocytes).
The precise aetiology of MCNS is not known, although the
primary hypothesis underlying the efficacy of anti-
inflammatory treatments for MCNS is that cytokines,
secreted by effector T cells, act on glomerular podocytes,
resulting in altered permeability of the glomerular filtration
barrier to plasma proteins.
A single injection of puromycin aminonucleoside (PAN)
in rats is a model of human MCNS, comprising all its clini-
cal features including massive proteinuria, oedema,
hypoalbuminaemia, hypercholesterolaemia, responsiveness
to glucocorticoid therapy and a absence of immune depos-
its in the glomeruli. The acute phase of PAN-NS lasts
approximately 2 weeks, followed by a recovery phase with
complete remission of proteinuria. However, proteinuria
recurs within 8 weeks after PAN injection, and glomerular
injury progresses leading to extensive glomerular sclerosis
[1].
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The renal insufficiency and massive proteinuria that
occurs during the acute phase of PAN-NS is thought to be
due to direct action of the drug on the glomerular podocyte
[2], although glomerular and interstitial accumulation of
activated macrophages occurs within a few days of PAN
injection [3]. Macrophages are heterogeneous phagocytic
cell populations that can acquire differential inflammation-
related phenotypes, proinflammatory (M1) and anti-
inflammatory (M2), depending on the nature of the stimuli
present in their microenvironment (e.g. cytokines). Inter-
feron (IFN)-γ, secreted mainly by activated T helper type 1
(Th1) lymphocytes, natural killer (NK) and NK T cells,
plays a crucial role in the development of M1 macrophages
[4]. Macrophage infiltration into glomeruli in PAN-NS
coincides with acute renal insufficiency, and is greatest
during the peak of proteinuria [5]. The number and activa-
tion state of infiltrated macrophages has also been shown to
correlate with the severity of renal damage and disease pro-
gression [6]. These results suggest that the macrophage
infiltration observed during the late acute phase of PAN-NS
may have an important role in the glomerular injury
induced by PAN, and may also contribute to
glomerulosclerosis in the later, chronic phase of PAN-NS
and in human glomerular disease.
The role of chemokines and their receptors in the precise
co-ordination of inflammatory cell trafficking into
damaged kidney tissue has been well established [7]. Within
glomerular tissue, chemokines and their receptors are
expressed in resident as well as in infiltrating cells. Among
them, IFN-γ-inducible protein of 10 kD (IP-10/CXCL10), a
member of the α (C-X-C) subfamily and a known T cell
and monocyte chemoattractant [8], has been reported to
contribute to the severity of kidney diseases in several
animal models of nephrosis [9]. In cultured glomerular
mesangial cells, CXCL10 was highly induced by stimulation
with proinflammatory stimuli such as lipopolysaccharide
(LPS), immune complexes, IFN-γ and tumour necrosis
factor (TNF)-α [10]. However, podocytes expressed the
highest levels of CXCL10 in the glomerulus, and CXCL10
could modulate expression of podocyte slit diaphragm pro-
teins [11]. The precise role of podocyte CXCL10, as well as
the mechanism of macrophage influx and their activation
status, remains elusive in PAN-NS.
In this study, we present data supporting the hypothesis
that a deficient T cell response is protective in PAN-NS in
the latter stage of the acute phase of the disease. We con-
firmed that nude (Foxn1rnu/rnu) rats developed less proteinu-
ria 12 days after induction of NS than immunocompetent
control Wistar rats. The remarkable reduction of plasma
IFN-γ, and the absence of infiltrating macrophages and
glomerular CXCL10 production in nude rats, led us to
propose a mechanistic model of glomerular injury. We
hypothesized that significant glomerular injury occurs from
release of IFN-γ by activated Th1 lymphocytes, leading to
production of CXCL10 by glomerular podocytes, and the
subsequent recruitment of monocyte-derived macrophages
from the blood into the injured kidneys by CXCL10.
Materials and methods
Disease model
A single intravenous tail vein injection of 50 mg pf
puromycin aminonucleoside (Sigma Aldrich, St Louis, MO,
USA) per kg total body weight on day 0 was used to induce
PAN-NS in male Wistar and athymic nude (Foxn1rnu/rnu) rats
weighing ∼200 g (Harlan Laboratories, Indianapolis, IN,
USA). Animals injected with saline vehicle served as con-
trols. Macrophage depletion was by intraperitoneal injec-
tion of 5 mg clodronate liposome (CL) on days 4, 7 and 10
after PAN injection. Clodronate (Roche Diagnostics Corpo-
ration, Indianapolis, IN, USA) was encapsulated by Dr Nico
van Rooijen [12]. Proteinuria was measured in urine col-
lected for 24-h periods by a modified Bradford assay [13].
After euthanasia, kidneys were collected and cortex tissue
isolated, embedded in optical cutting temperature com-
pound (OCT) (Tissue-Tek, Torrance, CA, USA), or used for
isolation of glomeruli by graded sieving [14]. All animal
procedures were conducted in compliance with the regula-
tions of the Institutional Animal Care and Use Committee
at Nationwide Children’s Hospital.
Cell culture
The human podocyte cell line was the kind gift of Moin
Saleem, and was cultivated and differentiated as described
previously [15]. Cells were treated for 6 h with 10 ng/ml
IFN-γ and TNF-α (R&D Systems, Minneapolis, MN, USA)
in fresh culture medium containing 1% fetal bovine serum.
After medium change, the cells were cultured for an addi-
tional 24 h. Conditioned medium was removed, clarified by
centrifugation and stored at −80°C.
The human monocytic cell line THP-1 [American Type
Culture Collection, Manassas, VA, USA (ATCC no. TIB-
202] was cultured in RPMI-1640 supplemented with
0·05 mM 2-mercaptoethanol, penicillin/streptomycin and
10% fetal bovine serum in a humidified 5% CO2 incubator
at 37°C.
Cytokine measurements
Blood was collected from rats, centrifuged, and cytokine
concentrations were measured in plasma using the Milliplex
MAP Rat Cytokine/Chemokine assay (Millipore, Billerica,
MA, USA). Results were read using the Bio-Plex 200 system
(Bio-Rad, Hercules, CA, USA). In a separate analysis, the
quantity of IFN-γ was measured by enzyme-linked immu-
nosorbent assay (ELISA) according to the manufacturer’s
protocol (R&D Systems).
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Immunofluorescence microscopy
Cryostat sections of 5-μm thickness were cut and fixed for
30 min in 2% paraformaldehyde in phosphate-buffered
saline (PBS). After washing, sections were incubated in lysis/
blocking buffer (5% normal donkey serum with 0·3%
Triton X-100 in PBS) for 1 h and incubated with primary
antibodies overnight at 4°C. Primary antibodies were
directed against synaptopodin (#H-140; Santa Cruz Bio-
technology, Santa Cruz, CA, USA), CD68 (ED1) and CD3
(both from AbD Serotec, Raleigh, NC, USA). Sections were
washed in 0·05% Tween-20 in PBS, incubated with appro-
priate DyLight 594- and 488-conjugated secondary anti-
bodies (Jackson Immunoresearch, West Grove, PA, USA) for
1 h, washed and mounted [Prolong Anti-fade Gold with
4′,6-diamidino-2-phenylindole (DAPI); Invitrogen, San
Diego, CA, USA]. Immunofluorescence microscopy was
performed as described previously [16]. Micrographs were
adjusted for brightness and contrast using Adobe
Photoshop (Adobe Systems, San Jose, CA, USA).
Macrophages (ED1+) and T lymphocytes (CD3+) cells were
counted in eight glomerular sections from each rat. Intra-
glomerular cells were those within Bowman’s capsule, while
peri-glomerular cells were within ∼1 glomerular diameter.
Quantitative real-time–PCR (qRT–PCR)
Total RNA was extracted from glomeruli using the Trizol®
reagent (Life Technologies, Grand Island, NY, USA), and
reverse-transcribed using high-capacity cDNA reverse tran-
scription (Applied Biosystems, Foster City, CA, USA).
Quantitative real-time PCR was performed on the iQ5 (Bio-
Rad,) using Absolute Blue™ SYBR® Green Supermix
(Thermo Fischer, Waltham, MA, USA). cDNA transcribed
from normal kidney cortex RNA (BioChain, Newark, CA,
USA) was used to create standard curves. Melt curve analy-
sis and agarose gel electrophoresis were performed to
ensure a single major product of the proper molecular
weight. After normalization to the housekeeping Rpl19
gene, the expression levels were calculated using the ΔΔCt
method of Pfaffl [17]. Primers (Table 1) were designed
using PrimerBLAST (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/).
Migration assay
Monocytic (THP-1, 2·5 × 105/well) cells were suspended in
conditioned medium from vehicle-treated MS13 cells and
loaded into the upper compartments of chemotaxis chambers
(5 μm pore Transwell; Costar, Lowell, MA, USA). Lower com-
partments were loaded with the same conditioned media con-
taining 10, 50 and 250 ng/ml rhCXCL10 (rhCXCL10),
30 ng/ml monocyte chemoattractant protein-1 (MCP-1)
(R&D Systems), 10 nM N-formylmethionyl-leucyl-
phenylalanine (fMLP) (Sigma Aldrich) or with conditioned
medium from MS13 cultures collected 1 day after treatment
with IFN-γ, TNF-α or both. THP-1 cells were allowed to
migrate for 180 min, and the number of cells that migrated
into the lower chamber was measured by flow cytometry nor-
malized to added fluorescein isothiocyanate (FITC)-labelled
beads. For neutralization experiments, culture medium was
pretreated for 30 min with 2 μg neutralizing antibody/ml.
Results
PAN nephrosis increased serum IFN-γ in Wistar but
not nude rats
To assess signs of systemic inflammation in Wistar rats
upon PAN-NS, we tested serum levels of an extensive panel
of cytokines at 12 days after injection with PAN. Signifi-
cantly greater concentrations of Th2 cytokines IL-4
(124 ± 53 versus 51 ± 6 pg/ml), IL-13 (244 ± 55 versus
126 ± 23), and especially the Th1 cytokine IFN-γ (292 ± 60
versus 17 ± 12), were found in serum from PAN-induced
Wistar rats compared to vehicle-treated controls (Fig. 1a).
No differences were observed in the plasma concentrations
of IL-1β, IL-6, IL-17, IL-18, regulated upon activation
normal T cell expressed and secreted (RANTES) or TNF-α
(data not shown). Because of the significant increase in
serum level of IFN-γ in the Wistar rat, we sought to evaluate
the role of T cells in the production of this type-1 cytokine.
Table 1. Primer sequences for quantitative real-time polymerase chain reaction (PCR).
Gene Forward primer Reverse primer
Cxcl1 5′-GCAAGAGCATGCACGTGGTCTCC-3′ 5′-AGGACAGCTGGGGCCGATCTC-3′
Ccl2 5′-GAGGCCAGCCCAGAAACCAGC-3′ 5′-TGGGGCATTAACTGCATCTGGC-3′
Ccl3 5′-AGGTCTCCACCGCTGCCCTT-3′ 5′-CTTGGTCAGGAAAATGACACCCGGC-3′
Ccl4 5′-AGCACCAATAGGCTCTGACCCTCC-3′ 5′-TCGCTGGGGTCGGCACAGAT-3′
Cxcl9 5′-CACTGTGGAGTTCGAGGAACCCT-3′ 5′-TGTGCCTTGGCTGGTGCTGA-3′
Cxcl10 5′-GAAGCACCATGAACCCAAGT-3′ 5′-CAACATGCGGACAGGATAGA-3′
Cxcl11 5′-GGCCACAACGGTTCCAGGCTT-3′ 5′-GCTTGGATGTGGGGTCCAGGC-3′
Cd169 5′-CCCCACCCGCTCCGTCATCT-3′ 5′-TGGGGGCATGCTGCACTTGT-3′
Nos2 5′-TGGAGGCCTTGTGTCAGCCCT-3′ 5′-AGGCAGCAGGCACACGCAAT-3′
Rpl19 5′-CCACAAACTGAAGGCAGAC-3′ 5′-TCTTGGTCTCTTCCTCCTTG-3′
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Thus, in a separate experiment, we measured IFN-γ concen-
trations in serum from controls (sham-injected), Wistar
and nude rats with PAN-NS (Fig. 1b). Twelve days after
PAN injection, a significant increase in serum IFN-γ was
found in blood from Wistar rats (437 ± 54 pg/ml), but not
from nude rats (25 ± 2), compared with sham-injected
Wistar controls (15 ± 4).
Proteinuria and podocyte injury after
PAN-induced nephrosis
Proteinuria was measured at several time-points after PAN
injection in both nude and Wistar rats, as well as in Wistar
rats that had been depleted of macrophages after the initial
development of proteinuria (Fig. 2a). Proteinuria at day 12
was significantly less in both nude (221 ± 62 mg/24 h) and
macrophage-depleted Wistar rats (272 ± 104) than in
Wistar rats (601 ± 56).
To assess injury to the glomerular podocyte in these
models, synaptopodin was visualized in frozen sections
obtained from rats euthanized on day 12 (Fig. 2b). As
expected, anti-synaptopodin antibodies labelled capillary
loops in glomeruli, a staining pattern characteristic of
glomerular podocytes. In sections from control animals
(sham-injected Wistar rats), podocyte labelling was strong
and in the form of a continuous line outlining the capillary
lumen. This pattern of staining was almost entirely dis-
rupted in Wistar rats at day 12 of the PAN model. However,
in both Wistar rats that had been depleted of macrophages
and in nude rats there was much less disruption of the
orderly capillary loop staining pattern by PAN, and the
intensity of synaptopodin labelling was comparable to
control animals. These results demonstrated that both
macrophage depletion and the absence of mature T cells
partially prevented the injury to glomerular podocytes that
led to massive proteinuria in the PAN model of nephrotic
syndrome.
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Fig. 1. Serum interferon (IFN)-γ is induced at the peak of proteinuria
induced by puromycin aminonucleoside (PAN) in Wistar but not
nude (Foxn1rnu/rnu) rats. (a) Serum cytokine concentrations in blood
samples taken from Wistar rats at 12 days after injection with vehicle
alone (n = 4) or PAN (n = 8). (b) Serum IFN-γ concentrations in
blood samples taken from Wistar or nude rats at 12 days after
injection with vehicle alone (n = 4) or PAN (n = 8). Results are
expressed as means ± standard error; *P < 0·05; **P < 0·01 compared
with vehicle alone by unpaired, two-tailed t-test.
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Fig. 2. Proteinuria and podocyte injury in late stages of acute puromycin aminonucleoside (PAN) nephrosis are greater in Wistar rats than in nude
rats, or in Wistar rats depleted of macrophages. (a) Plot of protein concentrations in 24-h urine samples taken at various times after PAN injection
from Wistar (Wistar-PAN, n = 8) nude rats (nude-PAN, n = 4) and from Wistar rats whose macrophages were depleted by three intraperitoneal (i.p.)
injections of clodronate liposomes at 4, 7 and 10 days after PAN injection (Wistar-PAN-CL, n = 4). Results are expressed as means ± standard error;
**P < 0·01 compared with nude-PAN and #P < 0·05 compared with Wistar-PAN-CL by analysis of variance (anova) followed by Bonferroni’s
post-test. (b) Micrographs visualizing anti-synaptopodin antibody labelling of representative glomeruli in frozen sections from the same animals
used in the experiment shown in (a), along with sham-injected control animals (control). Frozen sections were obtained from animals killked 12
days after PAN injection.
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Macrophage infiltration 12 days after PAN was greater
in Wistar than nude rats
There was no significant intra-glomerular (IG) or the peri-
glomerular (PG) infiltration of CD3+ T lymphocytes in
nude and Wistar rats 12 days after injection with vehicle
alone or PAN (data not shown). Few activated (ED1+)
macrophages were observed in glomerular sections from
Wistar or nude rats injected with vehicle alone (IG
Wistar = 0·49 ± 0·12; IG nude = 0·40 ± 0·10; PG Wistar =
0·71 ± 0·11; PG nude = 0·64 ± 0·07 ED1+ cells/glomerulus,
Fig. 3a,b) or from nude rats injected with PAN
(IG = 0·40 ± 0·05; IG = 0·60 ± 0·10, Fig. 3a,b). In contrast,
there was significant intra- and peri-glomerular influx of
ED1+ cells in Wistar rats injected with PAN (IG = 6·1 ± 0·4;
PG = 6·3 ± 0·7, Fig. 3a,b). We confirmed that injections of
clodronate (CL), beginning just after initial development of
proteinuria in Wistar rats on day 5, effectively prevented
accumulation of peri- and intra-glomerular macrophages
(IG = 0·96 ± 0·23; PG = 0·42 ± 0·36, Fig. 3b). As shown in
Fig. 3c, the glomerular expression of genes encoding an
activated macrophage marker (Cd169), and an enzyme
characteristic of M1 macrophages (iNOS2), were also
elevated in Wistar rats injected with PAN (Cd169 =
1·3 ± 0·17; Nos2 = 0·79 ± 0·18, fold change compared to
normal kidney cortex) compared to vehicle-treated controls
(Cd169 = 0·10 ± 0·03; Nos2 = 0·12 ± 0·06) and nude rats
injected with PAN (Cd169 = 0·09 ± 0·02; Nos2 = 0·24 ±
0·11). In contrast, there were no differences between groups
in the glomerular expression of Cd163, which encodes a
marker for alternatively activated M2 macrophages.
Podocyte Cxcl10 and Cxcl11 expression in vitro and
in vivo
We hypothesized that the glomerular and peri-glomerular
macrophage infiltration in Wistar rats during PAN-NS was
a result of monocyte chemoattractants released from
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Fig. 3. Activated (ED1+) macrophages accumulate in the glomerulus and peri-glomerular areas of Wistar rats [Wistar-puromycin aminonucleoside
(PAN)], but not of nude rats (nude-PAN) or macrophage-depleted Wistar rats (Wistar-PAN-CL), during the late stage of acute PAN nephrosis. (a)
Representative micrographs of glomeruli labelled with antibodies directed against ED1 (green), synaptopodin (red) and 4′,6-diamidino-2-
phenylindole (DAPI) (blue) from Wistar rats injected with vehicle alone (control) or PAN (Wistar-PAN), or from nude rats injected with PAN
(nude-PAN). The arrows show positions of glomerular and peri-glomerular activated (ED1+) macrophages. Results in studies of macrophage-
depleted Wistar rats were similar to those shown for nude rats (not shown). Quantitative results of immunofluorescence analyses are shown in plots
of intra- and peri-glomerular macrophage counts from these animals (b), including macrophage-depleted Wistar rats (Wistar-PAN-CL). Results are
expressed as means ± standard error (s.e.), n = 4/group; **P < 0·01 compared with vehicle alone, ##P < 0·01 compared to nude-PAN, @@P < 0·01
compared to Wistar-PAN-CL. Shown in (d) are plots of the mRNA expression of markers of proinflammatory activated macrophages (Cd169, Nos2),
and of alternatively activated macrophages (Cd163). Results are expressed as means ± s.e., n = 4/group; **P < 0·01 compared to vehicle alone and
##P < 0·01 compared to nude-PAN.
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glomerular cells, most probably podocytes. To test this
hypothesis, we measured glomerular expression of the
chemokines Cxcl1, Cxcl9, Cxcl10, Cxcl11, Ccl2 (MCP-1),
Ccl3 (MIP-1α) and Ccl4 (MIP-1β) (Fig. 4a). The most
notable change was in the expression of members of C-X-C
α chemokines, Cxcl10 and Cxcl11. Both were significantly
greater in glomeruli from Wistar rats 12 days after PAN
injection (Cxcl10 = 4·4 ± 1·1, Cxcl11 = 3·6 ± 0·53 fold versus
normal kidney cortex) compared to controls injected with
vehicle alone (Cxcl10 = 0·11 ± 0·03, Cxcl11 = 1·6 ± 0·37).
Strikingly, the expression of Cxcl10 and Cxcl11 in PAN-
treated nude rats was indistinguishable from expression in
control, sham-injected animals (Cxcl10 = 0·18 ± 0·05,
Cxcl11 = 0·24 ± 0·04). Although Ccl3 (MIP-1α) expression
was modestly increased in the PAN-nude compared to the
PAN-Wistar, this difference was not statistically significant
when compared to control. No significant differences were
observed in the expression levels of CXCL1, CXCL9, CCL2
or CCL4 in PAN-nude or PAN-Wistar compared to
controls.
Several cell types in response to IFN-γ secrete the
chemokines CXCL10 and CXCL11; therefore, to determine
whether this cytokine induced the secretion of C-X-C or
C-C chemokines, we stimulated human podocytes with
IFN-γ and TNF-α (Fig. 4b) and measured the relative
expression of a set of chemokines similar to those shown in
Fig. 4a. As expected, the combination of IFN-γ plus TNF-α
resulted in a potent type-1 immune stimulus that signifi-
cantly increased the expression of not only the IFN-γ induc-
ible chemokines CXCL9, CXCL10 and CXCL11, but also the
main macrophage chemoattractants CCl2 (MCP-1), CCL3
(MIP-1α) and CCL4 (MIP-1α). These results support the
hypothesis that podocytes act as initiators of macrophage
recruitment in response to cytokine stimulation.
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Fig. 4. The expression of Cxcl10 and Cxcl11 is
induced during late acute puromycin
aminonucleoside (PAN) nephrosis in Wistar but
not nude rats, and synergistically by interferon
(IFN)-γ and tumour necrosis factor (TNF)-α in
cultured human podocytes. (a) Plots of mRNA
expression of various chemokines, relative to
normal kidney cortex and normalized to Rpl19.
The mRNA expression of genes encoding the
C-X-C chemokines (Cxcl1, Cxcl9, Cxcl10,
Cxcl11) as well as C-C chemokines (Ccl2, Ccl3,
Ccl4) was evaluated in glomeruli isolated 12
days after Wistar or nude rats were injected with
PAN (PAN-Wistar, PAN-nude), or with vehicle
alone (control). Results are expressed as
means ± standard error (s.e.), n = 4/group;
*P < 0·05 compared with vehicle alone;
**P < 0·01 or ##P < 0·01 compared with
Wistar-PAN and vehicle alone. (b) Normalized
expression of similar set of C-X-C and C-C
chemokine genes as in (a). The mRNA
expression was evaluated in cultured human
podocytes after 4 h of treatment with IFN-γ,
TNF-α or both cytokines together (each at
10 ng/ml). Results are expressed as means ± s.e.,
n = 6/group, **P < 0·01 compared with control,
##P < 0·01 compared with IFN-γ or ++P < 0·01
compared with TNF-α.
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THP-1 monocytic cell chemotaxis is increased by
CXCL10, but not CXCL11
For determining the specific effect of the chemoattractants
released by podocytes in response to cytokine stimulation,
we measured monocyte chemotaxis in response to superna-
tants from cultured podocytes treated with the type-1
immune-inducing stimuli IFN-γ and TNF-α. As only
expression of Cxcl10 and Cxcl11 was induced in vivo in glo-
meruli during the course of PAN-NS in Wistar rats, we
focused on these chemokines as potential chemoattractants
for circulating monocytes. We first confirmed that recombi-
nant human CXCL10 and CXCL11 could induce
chemotaxis of a cultured monocyte cell line (THP-1), and
found more than half-maximal stimulation at 5 ng/ml
CXCL10/ml (Fig. 5a) compared to half-maximal stimula-
tion with ∼35 ng recombinant human (rh)CXCL11/ml
(Fig. 5b). The maximum stimulation of THP-1 chemotaxis
by CXCL10 was comparable to that induced by
chemoattractants known to induce THP-1 chemotaxis,
MCP-1 [18] (Fig. 5a), while maximal rhCXCL11 stimula-
tion was only ∼25% of these values (Fig. 5b). Chemotaxis
induced by both chemokines could be abrogated completely
by blocking antibodies, but was not affected by blocking
antibodies directed against the other chemokine (Fig. 5a,b).
Chemotaxis of THP-1 cells was increased by conditioned
medium from human podocyte cultures stimulated with
IFN-γ (3·2 ± 0·04-fold greater than control) or TNF-α
(3·5 ± 0·13, Fig. 5b). Medium from podocytes stimulated
with both IFN-γ and TNF-α induced greater THP-1
chemotaxis (6·8 ± 0·54) than medium from cells stimulated
with either cytokine alone. Chemotaxis induced by medium
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Fig. 5. CXCL10 produced by cultured human podocytes in response to interferon (IFN)-γ and tumour necrosis factor (TNF)-α induces monocyte
migration. The chemotactic index was calculated as the fold increase, compared to sham-treated controls, in the number of THP-1 monocytes
migrating across a 5-μm-pore membrane in response to chemoattractants. (a) Migration after incubation over wells containing various
concentrations of recombinant CXCL10, or with 250 ng of CXCL10/ml preincubated with neutralizing antibodies against CXCL10 or CXCL11. (b)
Migration after incubation over wells containing various concentrations of recombinant CXCL11, or with 250 ng of CXCL11/ml preincubated with
neutralizing antibodies against CXCL10 or CXCL11. (c) Migration after incubation over wells containing culture supernatants from human
podocytes collected 24 h after a 6 h treatment with IFN-γ, or TNF-α + IFN-γ. (d) Migration after incubation over wells containing culture
supernatants from human podocytes collected 24 h after a 6 h treatment with either type 1 stimulation [lipopolysaccharide (LPS) + IFN-γ, or
TNF-α + IFN-γ] or type 1 + type 2 stimulation (TNF-α + IFN-γ + IL-4 + IL-13) or type 2 cytokines only (IL-4 + IL-13). Control supernatants are
from untreated podocyte cultures. The chemoattractant CCL2 [monocyte chemoattractant protein-1 (MCP-1)] was used as positive control. Results
are expressed as mean ± standard error, n = 4/group; **P < 0·01 compared to control.
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from podocytes treated with IFN-γ and TNF-α was blocked
completely by preincubation with anti-CXCL10 blocking
antibody (1·3 ± 0·08), but was not affected significantly by
anti-CXCL11 blocking antibody (5·7 ± 0·49). To test the
effect of type-2 cytokines on the production of IFN-γ
inducible chemokines, we performed an additional set of
experiments in which the prototypical type-1 stimuli,
LPS + IFN-γ or TNF-α + IFN-γ, were added to human
podocyte cultures. The conditioned media obtained from
these cultures induced strong chemotactic responses in
THP-1 cells (Fig. 5d). In contrast, the type-2 stimuli,
IL-4 + IL-13, were unable to induce production of THP-1
chemoattractants by human podocytes. Interestingly, the
treatment of human podocytes with the combination
IL-4 + IL-13 only modestly reduced the ability of IFN-γ to
induce secretion of THP-1 chemoattractants into the
culture medium. These results demonstrated that IFN-γ,
enhanced by TNF-α, induced secretion of a major
monocyte chemoattractant by podocytes that blocking anti-
body experiments confirmed to be CXCL10.
Discussion
In the current study we found that nude rats, lacking
mature T lymphocytes, developed less proteinuria in the
late acute stage of PAN nephrosis than immune-competent
Wistar rats. The greater proteinuria in Wistar rats was asso-
ciated with increased serum concentration of IFN-γ,
glomerular Cxcl10 and Cxcl11 mRNA expression and peri-
and intra-glomerular infiltration of activated macrophages,
none of which were observed in similarly treated nude rats.
We found that podocytes responded to IFN-γ and TNF-α
stimulation by release of CXCL10 capable of promoting
monocyte chemotaxis. Importantly, we also showed that
macrophage depletion after the initial development of pro-
teinuria was sufficient to reduce the greater proteinuria in
PAN-treated Wistar rats to the same level as in nude rats.
Together, these results suggest that increased release of
TNF-α from glomeruli [19], and IFN-γ by T lymphocytes,
leads to production of CXCL10 by podocytes that attracts
activated monocytes/macrophages to exacerbate glomerular
injury.
Both innate and adaptive immune cells can produce
IFN-γ. For instance, in response to stress or tissue damage,
NK cells are important innate early secretors of this
cytokine, which can prime macrophages to secrete
proinflammatory cytokines as well as oxygen and nitrogen
radicals to increase their injurious capacity [20]. It has been
reported that nude (Foxn1rnu/rnu) rats have more alloreactive
NK cells in the blood and spleen than heterozygous
Foxn1rnu/+ littermates [21]. However, the production of
IFN-γ by NK cells is transient and insufficient to maintain
populations of activated macrophages, and antigen-specific
Th1 helper cells are required for sustained production of
IFN-γ [22]. Thus, our observation that nude rats fail to
maintain the high serum concentrations of IFN-γ found in
Wistar rats during PAN-NS demonstrates that this is a con-
sequence of the lack of a functional Th1 immune response.
Previous work confirmed the role of IFN-γ in the develop-
ment of glomerular injury, as crescentic glomerulonephritis
in a mouse model was ameliorated by antibodies directed
against IFN-γ and in IFN-γ-deficient mice [23]. In addition,
our conclusion that IFN-γ released by T lymphocytes is
required for activated macrophage recruitment is directly
supported by bone marrow transplant studies that demon-
strated IFN-γ derived from both renal and bone marrow
cells is required for renal recruitment of leucocytes in a
murine model of crescentic glomerulonephritis [24].
Previous reports show that there is renal infiltration of
immune cells during acute PAN nephrosis [25], and that
infiltration of monocytes and activated T lymphocytes con-
tributes to development of chronic renal damage [26,27].
We observed infiltration of activated (ED1+) macrophages,
but not CD3+ T lymphocytes, in Wistar rats at the peak of
the proteinuria induced by PAN (12 days after injection),
consistent with a previous study that found increased
glomerular ED1+ macrophage infiltration in Sprague–
Dawley rats at the same time after PAN injection [28]. Infil-
tration of T lymphocytes into the glomerulus has also been
observed in PAN-NS [29], but only at 5–7 days after PAN
injection, consistent with our finding of no significant later
infiltration of CD3+ T lymphocytes in any rats. The conclu-
sion that early infiltration of T lymphocytes does not con-
tribute to glomerular injury is supported by a study that
depleted T lymphocytes by daily injections of OX19 anti-
body, and failed to detect any change in proteinuria or
macrophage infiltration in PAN-NS in Lewis rats [30].
However, in this study proteinuria was followed only until
day 8 after PAN injection, too early to observe the decreased
proteinuria we observed in nude rats at day 12. Serum levels
of major T cell cytokines such as IFN-γ, IL-4 and IL-13,
cytokines critical for the activation and/or suppression of
macrophage function and chemotaxis into injured tissues,
were also not measured in this study. In addition, IFN-γ is
not only produced by T cells, but also by NK T cells [31,32].
As the thymus is the primary site of NK T cell differentia-
tion from double-positive thymocytes upon interaction
with the thymic CD1d molecule [33], this could addition-
ally explain the blunted IFN-γ response in our studies using
nude rats. The depleted antibody used in Eddy et al.’s study
were not able to deplete NK T cells in the periphery, as
those cells do not express CD5 or CD8α, the target antigens
for OX19 and OX8 antibodies, respectively [34]. Therefore,
this treatment is not sufficient to eliminate NK T cells in
vivo [35]. Overall, the fact that Eddy et al. still observed
infiltrating macrophages in their studies after depletion of T
cells could be explained by the effect of IFN-γ secreted from
NK T cells. Moreover, these macrophages were observed in
the tubulointerstitial compartment, which implied that the
development of nephritis as a chronic consequence of initial
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nephrosis accompanied acute-phase PAN injury. In con-
trast, in our studies we examined intra- and extra-
glomerular macrophages as a potential injurious factor.
Indeed, we demonstrated that both secretion of the Th1
cytokine, IFN-γ, and the infiltration of activated
macrophages were required for the greater glomerular
injury apparent in Wistar rats in the late (12 days after
injection) acute phase of PAN nephrosis. The injurious
effect of infiltrating macrophages was also dependent on
their state of activation, as the infiltrating macrophages we
observed in Wistar rats expressed activation markers such as
inducible nitric oxide synthase (iNOS) and sialoadhesin
(CD169), but not CD163, a marker for alternatively acti-
vated M2 macrophages [36]. This is consistent with studies
that showed that activated but not resting macrophages
could increase renal injury in murine adriamycin-induced
nephrosis [6], and that macrophages isolated from normal
glomeruli behave like uncommitted, undifferentiated
macrophages, while those from nephritic glomeruli have the
characteristics of IFN-γ-primed, TNF-α-activated
macrophages [37]. Thus, the increased IFN-γ and TNF-α
during PAN-NS in Wistar rats is likely to be required for
both the production of CXCL10, that induces monocyte
infiltration (see below), and for the activation of
macrophages to render them injurious.
The C-X-C motif chemokine, CXCL10, was isolated
originally in a screen for genes induced by IFN-γ [38].
Functionally, CXCL10 is a proinflammatory chemokine
involved in orchestrating selective migration and adhesion
of blood leucocytes during Th1-mediated responses at the
sites of inflammation [39]. However, a variety of studies
demonstrated that CXCL10 is also a chemoattractant for
circulating monocytes, leading to accumulation of
macrophages in tissues [8,40]. In addition, mice deficient in
the CXCL10 receptor, CXCR3, have attenuated macrophage
accumulation in various models of inflammation [41,42].
Our finding that levels of serum IFN-γ are increased during
PAN nephrosis, along with previous work showing induc-
tion of renal TNF-α in the same model [19], and synergistic
induction of CXCL10 in response to IFN-γ and TNF-α
[43], led us to hypothesize that our observed differences in
proteinuria and macrophage infiltration between Wistar
and nude rats was a consequence of differential podocyte
CXCL10 induction. This hypothesis is supported by a study
that found an association of greater infiltration of M1
macrophages with greater renal TNF-α and CXCL10
expression in a murine model of Alport nephropathy [44].
The extra-renal origin of the activated macrophages is
supported by a study that depleted resident kidney
macrophages by irradiation without diminishing
macrophage accumulation during PAN nephrosis [30].
However, while CXCL10 expression was induced in the
early phase of development of Thy1·1 glomerulonephritis,
daily injections of an anti-CXCL10 blocking antibody was
shown to aggravate proteinuria [11]. Similarly, anti-
CXCL10 blocking antibody also exacerbated proteinuria in
the PAN model of nephrosis in rats [45]. While the authors
of these studies suggest that CXCL10 is necessary for main-
tenance of podocyte cell-cycle balance through action on
p27Kip1 and cyclins A and E, they observed increased pro-
teinuria due to CXCL10 blocking antibodies earlier in
PAN-NS than our findings, and the use of blocking anti-
bodies was associated with increased mesangiolysis and
matrix deposition, but not a decrease in glomerular ED1+
cells. This suggests that circulating anti-CXCL10 antibodies
target CXCL10 essential for mesangial cell function, but
podocyte CXCL10 and consequent macrophage recruit-
ment is largely unaffected by anti-CXCL10 antibodies due
to their exclusion by the glomerular filtration barrier.
In conclusion, our work provides strong evidence that in
the late acute phase of PAN-induced nephrosis, CXCL10
secreted from podocytes acts as a potent monocyte
chemoattractant, directing their migration into the injured
kidney to aggravate disease. Our macrophage depletion
experiments demonstrated that macrophages are necessary
for the increased proteinuria in late acute nephrosis in
Wistar rats, and our studies in nude rats demonstrated that
mature T lymphocytes are necessary for both glomerular
induction of Cxcl10 and macrophage infiltration. These
results are consistent with a role for T lymphocyte-derived
IFN-γ in both the activation of macrophages and the stimu-
lation of podocytes to produce CXCL10 to attract
monocytes. Together, our findings imply that the podocyte
response to circulating cytokines can lead to exacerbation of
inflammatory responses, potentially leading to progressive
glomerular disease and end-stage renal failure.
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